George · The Biohack Diaries
Stem Cells for Joints
Musculoskeletal injuries can be painful, troublesome and life-limiting. Over the past two decades there has been considerable interest in stem cells and tissue-engineering techniques in orthopaedic surgery, especially for difficult injuries of the musculoskeletal system. Stem cell therapy has been used successfully for bone and joint injuries and for osteoarthritis and cartilage defects, and in bone tissue engineering, where stem cells combined with scaffolds have given faster and better tissue healing.
In our Stem Cells for Joints treatment, mesenchymal stem cells from umbilical cord tissue are injected directly into the joint by an orthopaedic surgeon (for the back, into the muscles around the spine). It is for joint pain and wear in the knee, shoulder, elbow, ankle or back. The treatment takes about 30 minutes, needs no surgery and no overnight hospital stay, and you can return to daily life after the procedure.
This new cell therapy method is effective and evidence-based. Because it avoids open surgery, it also avoids the long and painful rehabilitation needed after invasive joint operations. This matters especially for older patients, for whom a long period of inactivity after surgery increases the risk of complications in other organ systems.
What it is and how it works
What stem cells are
Stem cells are a special type of cell with several unique abilities, which fall into three main groups:
They multiply themselves. One stem cell can divide into two daughter cells, again and again, to create a population of cells for the body's self-repair systems. When you cut your skin, for example, skin stem cells multiply as part of wound healing to create new skin and restore normal function.
They transform into many cell types. In the right environment, stem cells can become the cell types your body needs. Umbilical cord stem cells, for example, can multiply and transform into nerve cells, muscle cells, blood cells and bone cells. When the body is injured, stem cells use a mechanism called "homing" to travel from their source to the injured organ and start a tissue-repair cascade.
They renew the tissue they populate. By several mechanisms, including becoming the dominant cells in injured tissue, stem cells act as the provider and stimulator of repair and rejuvenation, like the conductor of an orchestra.
The body constantly makes stem cells in the bone marrow, and signals in the body direct them to where they are needed. A stem cell is an immature, basic cell that has not yet become, say, a skin cell, a muscle cell or a nerve cell. Stem cells are essential from conception until death: in the beginning, embryonic stem cells multiply and build every organ system, and throughout life, cells in every part of the body die and are replaced through stem cell regeneration. When our stem cells are impaired, we get sick; when they age, we age too. Stem cell treatments work by prompting damaged tissues to repair themselves, which is why they are called "regenerative" therapy.
The type of stem cells we use, and why
There are three major types of stem cells:
Embryonic stem cells are generally used only in research, as they have been linked with tumor formation.
Induced pluripotent stem cells (iPSCs), made by genetic engineering, are also still in the research phase and have shown some links to cancer.
Adult stem cells are the most commonly used cells in treatment and are not linked with tumor or cancer risk. They come from several sources, such as the umbilical cord, fat (liposuction) and menstrual blood.
We use adult mesenchymal stem cells (MSCs) from umbilical cord tissue, sometimes called Wharton's jelly. We chose this source because stem cells, like every other cell in the body, age with you. Umbilical cord stem cells come from the very start of life, age zero, and the younger the cell, the better the treatment tends to work. Umbilical cord stem cells are easy to obtain, need no surgery to harvest, and have a property called immune privilege, which makes them a universal donor.
Mesenchymal stem cells are known for their:
anti-inflammatory effects
tissue regeneration potential
immunomodulatory abilities
How stem cells help a damaged joint
When injected into a damaged joint, MSCs help reduce inflammation, repair cartilage and improve joint function, offering a non-surgical approach to healing. Researchers believe stem cells work in the joint by:
developing into essential cartilage cells
producing proteins called cytokines that slow the breakdown of cartilage and reduce pain
preventing the inflammation that can worsen arthritis
supplying growth factors that help stimulate tissue growth and strengthening the body's natural anti-inflammatory agents
Much of this happens through what scientists call a paracrine effect: the cells release bioactive molecules (cytokines, growth factors and signaling vesicles) that instruct your own joint cells to begin repairing themselves. They also shift the local immune environment from an inflamed state toward a healing one, and they protect cartilage from further breakdown. The research behind this is described in The science, below.
What it is for
Stem Cells for Joints is for joint pain and wear in the knee, shoulder, elbow, ankle or back. Among the treatments available today, stem cell treatment is one of the few that answers all the goals a patient with a worn or injured joint has:
Relief of painful symptoms. All of our patients treated for knee problems have said they would recommend stem cell treatment to people with the same problem.
Preventing further joint destruction. Stem cells slow down disease progression, with the aim of avoiding joint replacement.
Repairing injured joint structures, such as tendons, cartilage and the many other cell types of the joint.
Reducing inflammation, which is a key driver of pain and of osteoarthritis.
Conditions we treat include osteoarthritis and cartilage damage, sports injuries (ligament damage, meniscus tears), chronic tendon problems such as rotator cuff injury, shoulder tendinopathy and tennis elbow, post-traumatic ankle arthritis, and back pain from spinal joint wear and disc degeneration. Stem cells can also support recovery after orthopaedic surgery. The section Treatment by joint, below, covers each joint in detail.
Who it is for
You may benefit from Stem Cells for Joints if you:
have mild to moderate osteoarthritis (grade 1 to 3) in the knee, shoulder, elbow, ankle or spine
have chronic joint pain or stiffness that limits your daily activities
have a sports injury, such as ligament damage or a meniscus tear
want to avoid or delay joint replacement or other surgery
have not responded well to conventional treatments, or find that steroid injections and physiotherapy no longer help
want a faster recovery in one specific joint
prefer a natural, minimally invasive treatment with fewer side effects
Earlier treatment tends to give better results. We often wish we had met a patient sooner, before one damaged joint has caused problems in the joints around it and before surgery is on the table.
Who should not have it
Not everyone with joint pain is a candidate. Suitability depends on the cause and severity of the problem, your imaging and your overall health, and some conditions respond well while others respond only partially. Severe structural problems or nerve compression may still need surgical input. General reasons not to have stem cell therapy, or to wait, include:
Active infections, such as active diarrhea, a severe soft-tissue infection, or an active, uncontrolled viral infection such as hepatitis.
Cancer. Stem cell therapy is not a cancer treatment. Once you have been declared cancer-free, it can be a helpful choice during your recovery.
Pregnancy and the period after birth. Stem cell therapy can begin 6 months after giving birth.
Uncontrolled autoimmune conditions, such as active SLE or active inflammatory bowel disease, should settle before treatment.
Unrealistic expectations that the therapy cannot fulfil.
The treatment
The treatment takes about 30 minutes and needs no surgery and no overnight stay. The minimum stay in Bangkok is just one day.
Consultation and assessment. Your doctor reviews your medical history, examines the joint and looks at imaging if needed. No two patients have the same story, so we take time to listen and make sure you feel understood before the medical team makes the clinical assessment and plan. We set realistic expectations at this point.
Your plan. Your doctor discusses the most suitable number of cells and how often to treat. The number of sessions is always set by your doctor after an in-person assessment. Some patients benefit from one session, while others need two or three.
The injection. Because joint treatments are delicate, the injection is always given by an orthopaedic surgeon, not a general practitioner, supported by the nurses and team. The joint is numbed with local anesthesia only, so no general anesthesia is needed. The doctors use real-time ultrasound guidance so the stem cells reach the exact target area inside the joint capsule. You may feel brief discomfort.
Follow-up. We monitor and support you after treatment, in the clinic or remotely, including after you return home.
When a problem affects several places at once (for example several levels of the spine plus another joint), your doctor may suggest an IV stem cell infusion instead of, or as well as, a joint injection. Many patients combine IV stem cells for whole-body support with joint injections for local repair in the same treatment plan. See IV stem cells or joint injection? in The science.
Before and aftercare
Before treatment
Avoid strenuous exercise, or exercise that may cause injury such as skiing, around your treatment. Because stem cells home to sites of injury, we want them to focus on repairing your joint, not be distracted by new injuries.
After treatment
Because this is a local injection, downtime is minimal.
Rest for the first 24 hours and walk only when necessary.
Walking and normal daily activities can usually resume 24 hours after the injection.
Avoid strenuous exercise that loads the treated joint, such as jumping and jogging, for one month.
Gentle, guided rehabilitation afterward is an important part of the result, especially for tendon injuries such as the shoulder.
What you may feel
Side effects are minimal. The most common are mild pain, swelling and some stiffness at the injection site, which usually settle within a few days.
When to expect results
Improvement is gradual, because the cells work with your body's own healing. Some patients notice less pain and swelling within the first days; for knee arthritis, reduced pain and better function usually start to show within a month and keep increasing over time. Cartilage, tendon and disc repair unfold over weeks to months. How quickly you respond depends on many factors, and the better your general health, the faster your response is likely to be.
Quality and safety
The quality of the cells matters more than the number of cells. Our stem cells are:
Mesenchymal stem cells from umbilical cord tissue, grown xeno-free (no animal-derived materials), so no animal-related risks can contaminate them.
Tested before every procedure: each batch is checked for sterility, viability and cell count.
Documented: you receive a Certificate of Analysis for your case, showing full details of the stem cells used for your treatment.
Given without additives or anti-rejection drugs. High-quality cells carry no risk of rejection, so no anti-rejection medication is needed.
Our cells are produced in a Lab class 100 cleanroom, a controlled environment of the kind used to manufacture injectable drugs, and conform to general MSC criteria. They are cultured in phenol-red-free medium and made from fresh cord tissue that has never been frozen; fresh cord tissue yields higher-potency cells than frozen tissue (Cytotherapy, Volume 16, Issue 9). We use the same laboratory sources that large private hospitals use.
Mesenchymal stem cell therapy for blood diseases has been used for over 45 years and is a very safe treatment. Studies of stem cell injections for joints show that side effects are minimal: some people have temporary pain and swelling after the procedure, but the great majority have no adverse effects. Because we use lab-grown, screened cells and sterile protocols, the risk of infection or rejection is very low. We have never had a case that reported adverse side effects. All procedures are carried out under medical supervision, and you are monitored throughout.
Treatment by joint
Knee
Why knees wear out. The knee is a complex hinge joint that lets the leg move in several directions while carrying the whole body's weight. Every time we walk, run or jump, the knee stabilizes us and carries our weight; when we jump, the force on the knee can reach up to 10 times body weight. Even sitting flexes the knee and puts more pressure on the joint. Common causes of knee problems are:
injury to the knee or its parts, such as ligament or tendon injury, a torn meniscus or a fracture
aging, since osteoarthritis is a wear-and-tear disease
autoimmune disease, such as rheumatoid arthritis, which inflames and destroys the knee joint
Osteoarthritis of the knee. Osteoarthritis is one of the most common chronic degenerative disorders, and it very often affects the knee, wearing down the joint cartilage over time. It can also start after a knee injury such as a ligament tear, tendon damage or a fracture: the injured joint becomes unstable, which wears down the cartilage, and then the bone, the synovial lining, tendons, ligaments and muscles can be damaged too. As the bones lose their protective covering they rub against one another, causing pain, swelling and stiffness, and ultimately loss of function and mobility. If symptoms become severe, total knee replacement is an option; stem cell therapy can be an alternative to surgery. (Symptoms, risk factors and prevention of osteoarthritis are covered in The science.)
Knee pain treatment options. Knee pain is the most challenging part of knee disease, whether it comes from an acute injury or a chronic illness like osteoarthritis. Treatment options can be grouped by how far the joint has been destroyed:
Preventing knee destruction. The best treatment for any disease is prevention. As knee osteoarthritis is a wear-and-tear problem, lifestyle changes that reduce the workload on the knee are essential to prevent the disease or slow it down: losing weight if you are overweight, strengthening the muscles that support the knee, and avoiding postures that stress the knee joint.
Supportive treatment for pain. Most knee procedures fall into this group. The root cause of pain is inflammation, which many factors can trigger; at one stage of osteoarthritis, for example, the protective cartilage breaks down and the bones rub together, causing swelling and pain. Most treatments here give only temporary relief, and some cause harm when used long term or incorrectly: NSAID painkillers can cause kidney damage, and intra-articular steroid injections can make knee tendons fragile.
Knee replacement. Like a chair with a leg too broken to fix, a destroyed knee must be replaced. The problem is that our body is far more delicate than a chair, and there is still no artificial joint that works as well as, and moves in harmony with, the natural one. Knee replacement can cause complications such as infection, nerve injury, restricted movement, persistent pain and dissatisfaction, and the rate depends on the surgeon and the setting. That is why prevention is the best treatment for knee problems.
What stem cells do for the knee. Stem cell therapy for the knee is minimally invasive. It aims to:
slow the damage to cartilage and repair it
decrease inflammation and reduce pain
possibly delay or prevent the need for knee replacement surgery
What to expect. The orthopaedic surgeon injects the stem cells into the knee (intra-articular injection) under local anesthesia. Rest for 24 hours, return to walking and daily life after that, and avoid jumping, jogging and other strenuous knee exercise for one month.
Results. All of our patients treated for knee arthritis have had less knee pain and a better quality of life after treatment. We review every patient's progress one year after treatment for knee arthritis, and every patient has had more than 50% improvement in both pain and function. All of our past patients say they would recommend this treatment to people with the same problem.
What our patients say:
"Massive improvement in my knee. I would say better than when I was in my 20s. I haven't been able to squat for 20 years due to football injuries; now it's like I have a completely new set! Another good story to add to the hundreds you probably already have."
"I have lost over 6 kg since getting home, and my right knee is the best it's been since the operation... and it's still getting better! I am so happy with the result so far and want to thank you and your fabulous team for a truly unforgettable experience."
Shoulder
Rotator cuff injury. Rotator cuff injuries usually come from a combination of factors and can seriously affect quality of life. Overuse and repetitive stress, common in certain sports and jobs, together with aging and degeneration, make the rotator cuff tendons vulnerable. Trauma, such as a fall or a direct blow to the shoulder, can also tear the rotator cuff.
These injuries involve impingement, where the rotator cuff tendons are squeezed between the head of the upper arm bone (humeral head) and the acromion during overhead movements. Tendon degeneration, the gradual breakdown of tissue, and acute or chronic tears add to the problem.
Patients typically have persistent shoulder pain, both when moving the arm and at rest, and limited range of motion, especially reaching overhead or behind the back. Daily tasks such as lifting, dressing and sport become difficult, and pain can disturb sleep by making it hard to find a comfortable position.
Chronic shoulder tendinopathy and bursitis. Another common picture is chronic tendinopathy with bursitis: the tendons around the shoulder become worn and inflamed, and the small fluid-filled sac (bursa) that helps the joint glide becomes irritated and swollen. Everyday movements such as reaching up to a shelf, getting dressed or sleeping on that side become a daily struggle.
The limits of surgery and steroids. Rotator cuff tears have traditionally been treated with surgery to repair the damaged tendons. Yet the long-term success of surgery is debated: numerous studies suggest that, even with better techniques and materials, tendon-to-bone rotator cuff repairs fail in 30% to 94% of cases. The main problem appears to be biological. The delicate fibro-cartilaginous transition zone between the rotator cuff and the bone cannot regenerate after standard repair; instead, fibro-vascular scar tissue with poor mechanical properties forms.
Steroid injections can be very useful: they calm inflammation and often bring real relief. But they treat the inflammation, not the underlying wear in the tendon. Many patients find that each injection helps a little less, and for a shorter time. Repeated or high-dose corticosteroid injections into a joint can also weaken tendons, damage cartilage and raise the risk of joint infection, so the treatment meant to help can quietly erode the joint it is meant to protect. We call this the steroid cycle.
What stem cells do for the shoulder. Research has therefore shifted from improving only the mechanics of repair to improving the biological environment around it, using biological therapies such as growth factors, bone morphogenetic proteins (BMPs) and, notably, stem cells. The idea is that these can help regenerate the normal tendon-to-bone insertion while limiting scar tissue. Isolated growth factors and platelet-rich plasma have given variable results; stem cells stand out as more promising, because they promote the growth of new blood vessels (angiogenesis) and modulate inflammation during healing. Rather than only quieting inflammation, the aim is to support the body's own repair of the damaged tendon.
What to expect. We inject mesenchymal stem cells from umbilical cord tissue into the shoulder, delivered precisely to the damaged area. Improvement is not instant: expect modest changes in the first weeks and more meaningful improvement over several months, with gentle, guided rehabilitation as an important part of the result.
Patient stories.
A man in his early 40s, a keen tennis player, had multiple rotator cuff injuries. Arthroscopic surgery had not given him the relief he wanted, and he faced a second operation. After extensive research he flew from Canada for stem cell treatment with us. The injection went smoothly, and the results surpassed his expectations: his improvement was greater than after his surgery, and the treatment was less complicated, with a smoother recovery.
A patient with long-standing chronic shoulder tendinopathy and bursitis had already tried rest, physiotherapy, anti-inflammatory medication and more than one steroid injection. After reviewing the history and imaging, we agreed stem cell therapy was suitable. Changes were modest in the first weeks, as expected, but by around eight months the patient reported being roughly 80 to 90% better, sleeping comfortably, moving the arm freely and back to normal daily activities.
A patient from Australia, referred by a friend we had treated, had shoulder pain that began after a minor accident and years of steroid injections that never solved the problem. The assessment and injection were both done by our US-educated orthopaedic surgeon. At around eight months his shoulder was 80 to 90% back to normal, and he had returned to his sport and exercise routine, out of the steroid cycle and off the road that so often leads to surgery.
These stories come from real reviews our patients wrote on Google, retold with identifying details removed. There are no guarantees in medicine: biology differs from person to person, and one patient's strong result is never a promise to the next.
Elbow
Tennis elbow (lateral elbow tendinopathy). In tennis elbow, the tendons on the outer part of the elbow suffer tiny injuries that lead to degeneration. Despite the name, only about 10% of people with tennis elbow play tennis, though it is very common among mature amateur players, 75% of whom experience true tennis elbow. It is also seen in sports with repetitive wrist extension, radial deviation and forearm rotation, and it is more likely after age 40. The main complaints are pain, reduced grip strength and difficulty with daily activities, and it can seriously limit sport.
The microscopic injuries reduce the number of tenocytes (the specialized cells of tendons) through cell death, which impairs the production of collagen, the essential building block of tendons. The disorder involves vascular proliferation and hyaline degeneration of specific elbow tendons.
Most people with tennis elbow get better within a year, even without treatment. Traditional approaches include physiotherapy and anti-inflammatory medication. Corticosteroid injections are common but give only temporary relief, and long-term use can weaken tendons and increase the risk of rupture.
What stem cells do for the elbow. When non-surgical measures fall short, treating lateral elbow tendinopathy can be difficult. Biological stimulation that breaks the cycle of tendon tearing and promotes healing is then an appealing option. The goal of biological treatment is to heal the tendon, minimize scar tissue, and improve its structure and tensile strength. MSCs, which can self-renew and exist in an undifferentiated state, have attracted attention for improving tendon healing. Laboratory and animal studies suggest that MSCs may speed up tendon healing and improve its quality, and co-culture studies show that the crosstalk between cells switches on tendon-related genes, pointing to a therapeutic effect in tendinopathy.
What to expect. We inject mesenchymal stem cells from umbilical cord tissue into the elbow to target the problem inside the joint.
Ankle
How ankle injuries lead to arthritis. Ankle injuries are extremely common in active people, with sprains and fractures the two most frequent. Ankle arthritis is also common with age or after a sports injury. A severe sprain, fracture or dislocation can damage ligaments, cartilage and other supporting structures. This changes the biomechanics of the ankle: ligament damage makes the joint unstable and prone to giving way, joint loading changes, and the smooth cartilage surfaces may be damaged. Together, altered biomechanics, instability and cartilage damage cause post-traumatic arthritis, with gradual cartilage breakdown, inflammation and changes to the joint structure. Over time, wear on the damaged surfaces leads to osteoarthritis of the ankle, with pain, stiffness and loss of function.
A damaged ankle can also cause problems elsewhere. When one joint is compromised, the joints around it take extra load to compensate, and year after year that compensation creates new damage. We have treated a patient whose early ankle injury led to years of chronic ankle inflammation and, eventually, multiple bulging and herniated discs in the lower spine (see Back and spine).
Joint-sparing treatments. Ankle osteoarthritis is a real challenge, especially in young people after an injury. Traditional joint-sparing procedures such as arthroscopic debridement, arthrodiastasis and osteotomy have given variable results, with better outcomes when degeneration is limited. Osteotomy for malalignment is the universally accepted joint-sparing approach in partial ankle osteoarthritis, but the effectiveness of these traditional methods is often questioned.
We now understand that osteoarthritis affects not only cartilage but also bone and the synovial membrane, and that in its early stages the breakdown (catabolic activity) and cartilage loss can be reversed. This has led to biological treatments that aim to delay or prevent progression to end-stage surgery. Mesenchymal stem cells are a promising option because their immunomodulatory properties can control the destructive joint environment and their regenerative ability can address cartilage defects. MSCs regulate the cytokine cascade and reduce the release of metalloproteinases (enzymes that break down cartilage), helping restore the bone and cartilage tissue. Encouraging reports show MSCs seeded on scaffolds working in cartilage defects of non-degenerated joints, and bone marrow-derived cell transplantation is emerging as a promising way to control degeneration and restore bone and cartilage defects in ankle osteoarthritis.
What to expect. We inject mesenchymal stem cells from umbilical cord tissue into the ankle to target the problem inside the joint.
Patient stories. A man in his mid-30s, a former sports and martial arts enthusiast, had a severe ankle injury that led to chronic pain and then osteoarthritis. He had to give up all sport and gained weight. After trying various treatments without success, he came to us, and noticed that treatment was given by dedicated nurses and orthopaedic surgeons, unlike the GP-led checks at other clinics. Within one day he felt significant pain relief, which kept improving, and he gradually returned to sport. He asked us to share his story to encourage people in the early stages of ankle problems, because he firmly believes that earlier treatment gives better results.
Another patient wrote: "Had been thinking about getting stem cell therapy for many years now but couldn't find the right place. But all was answered after getting in touch. We came up with a plan to help increase mobility and decrease the severe pain in my ankle. The team made me feel very comfortable and at ease during the procedure. It was swift and simple. I'm already feeling a big difference! I'm glad I took the leap of faith."
Back and spine (including disc degeneration)
How the spine works. The spine is the body's central support. It keeps us upright and connects the pelvis, shoulders, head, chest, arms and legs. Although it is built from a chain of bones, it is flexible thanks to the spinal discs and elastic ligaments. It supports the weight of the head, torso and arms and lets the body move in every direction; the neck is its most flexible part. The bones of the spine also protect the spinal cord, which runs through the spinal canal.
The lower back has just five vertebrae. It supports the upper body and connects the spine to the pelvis, and because it constantly bears weight and moves in many directions, it is prone to wear, tear and injury.
The discs. The discs are the shock absorbers between the vertebrae, keeping the back flexible while resisting large forces in many directions. Each disc has two parts:
The annulus fibrosus, a tough outer layer. Its outer part contains nerves, so a tear there can be quite painful.
The nucleus pulposus, a jelly-like core. It contains proteins that make any tissue they touch tender and swollen; if they leak out to the nerves of the outer layer, they can cause a great deal of pain.
Unlike most tissues, the disc has a very small blood supply. Once damaged it cannot regenerate, and degeneration can unfold over 20 to 30 years.
Causes of back pain. Back pain can follow a sudden injury, and it does not take a major accident: a small twist on an unlucky day can damage the back. The most common cause of lower back pain, though, is gradual degeneration of the spinal joints. With age, wear and tear are inevitable. As cartilage between the spinal joints breaks down, it can inflame the surrounding tissue, and inflammation plus thinning cartilage increases friction in the joints, causing pain. Degeneration of the discs adds structural change, instability, inflammation and nerve ingrowth.
Discs degenerate with age and also because of:
Drying out. At birth the disc is about 80% water. As we age it dries out and absorbs shock less well.
Injuries, which can cause soreness, swelling and instability, for example in low back pain.
Sport and daily activity, which create tears in the outer part of the disc. By age 60, most people have some disc degeneration, although not all of them have back pain.
Symptoms of degenerative disc disease. A typical patient is active and otherwise healthy, in their 30s or 40s. Common symptoms are:
pain that is easier when walking or even running than when standing or sitting for long periods
feeling better lying down or changing position often
episodes of acute pain that last from a few days to a few months before easing, ranging from mild discomfort to severe pain, felt in the low back, thighs and buttocks or in the neck depending on the affected disc, and sometimes radiating to the arms and hands
pain that increases when sitting, when the discs of the lower back carry three times the load they carry when standing
pain that gets worse when lifting or twisting
tingling and numbness in the arms and legs
weakness in the leg muscles, or foot drop, an early sign of nerve root damage
Protecting your discs.
Keep good posture: avoid slumping in your chair, hunching over a desk or standing with your shoulders hunched. Sit and stand up straight.
Take a short break from sitting every 30 minutes.
Avoid sling bags; carry larger loads in a comfortable backpack using both straps.
Stop smoking. Smoking is believed to reduce the blood supply to the discs, which may lead to degeneration.
Strengthen your back, one of the most effective ways to prevent back pain, with back-strengthening and stretching exercise such as yoga at least 2 days a week.
Avoid heavy lifting. If you must lift something heavy, keep your back straight and bend your knees so your leg muscles do most of the work.
Stay active and eat a healthy diet, as being overweight stresses the back.
Conventional treatment. Treatment usually starts with non-invasive methods:
Conservative management: pain relief (medication and anti-inflammatory drugs, electrical stimulation, heat and ice, back braces); physical therapy to strengthen and stretch the back's supporting muscles and reduce flare-ups; lifestyle changes such as better posture, stopping smoking, weight management and avoiding prolonged sitting, which can reduce stress on the damaged disc and slow degeneration.
Interventional procedures: epidural steroid injections to reduce inflammation and pain; facet joint injections; radiofrequency ablation to disrupt nerve signals.
Surgery, for severe pain or major loss of function that does not respond to other treatment: discectomy (removing part of a disc); laminectomy (removing bone to enlarge the space); spinal fusion (joining two or more vertebrae, often after removing the disc and replacing it with a spacer or bone graft); partial or total artificial disc replacement.
As of now, there is no definitive solution for disc degeneration. Standard approaches such as lumbar fusion can relieve pain in some people, but results vary and may fade over time, which is why each patient's condition needs careful evaluation and why alternative or complementary approaches deserve consideration.
Why surgery is rarely our first choice. Each of these operations manages the symptom more than it fixes the root cause. Once the natural shock absorber is gone and the spine is fused, movement at that level becomes abnormal. The long-term concern is adjacent segment disease: the healthy segments next to a fusion work harder to make up for the rigid section and start to wear out themselves. A systematic review and meta-analysis found that about 36% of patients develop degeneration in the adjacent segment, and about 11% develop symptomatic adjacent segment disease, within two to seven years of lumbar fusion, with older age among the risk factors (The Spine Journal, 2023). Fixing one segment can set up the next one to fail. Nature rarely gives us a body part without a reason, and changing that design tends to carry a long-term cost.
We are also concerned that, from our own observation and published trend data, spinal surgery is being done on younger and younger patients. Studies report a rising rate of lumbar disc herniation in adolescents and young adults, driven largely by prolonged sitting, inactivity and poor posture (Frontiers in Surgery, 2022). That makes a conservative, root-cause-first approach more important than ever. Further background on these operations: Lumbar discectomy, Mayfield Brain & Spine; Spinal surgery: laminectomy and fusion, Aetna Clinical Policy Bulletin; Lumbar discectomy vs. fusion, Southeastern Orthopedics.
Possible complications of spine surgery. Every operation carries risks, and near the spinal cord they can be severe, sometimes leading to further pain, disability or corrective surgery. This list is not complete and does not replace a discussion of risks and benefits with your surgeon:
Infection at the surgical site or in the spine itself, although it occurs in less than 1% of spinal operations.
Bleeding during or after surgery that needs further treatment.
Nerve and spinal cord injury, causing loss of sensation or movement; the risk depends on the complexity of surgery and how close it is to nerves. Because each spinal nerve serves a specific area, the resulting disability depends on which nerves are injured.
Dural tear or cerebrospinal fluid leak, from damage to the dura, the covering of the spinal cord.
Hardware problems: screws, plates or rods that hold the spine while it heals can move, loosen or break, sometimes needing another operation.
Blood clots: deep vein thrombosis (clots in the leg veins, a frequent problem after many operations) or pulmonary embolism.
Failed fusion, when the vertebrae do not join.
Persistent pain: surgery does not always remove the pain, and some patients have ongoing or new pain.
Anesthesia complications: most spinal surgery needs general anesthesia, with a small risk of reactions to drugs, respiratory problems or complications from other medical conditions.
Sexual dysfunction, if a nerve supplying the pelvic region is injured.
What stem cells do for the back. Mesenchymal stem cell treatment for back pain is a safe, effective option supported by the growing field of regenerative medicine, and research into stem cells for discogenic back pain supports its safety and efficacy. Our back treatment is a simple intramuscular injection of mesenchymal stem cells from umbilical cord tissue into the muscles around the spine, given by the orthopaedic surgeon. It uses the homing effect of stem cells, which directs them to the site of pain and inflammation, to make the most of their regenerative potential safely. When problems sit in more than one place, such as several levels of the spine plus another joint, injecting each site one by one is not the most sensible approach, and your doctor may recommend an IV infusion instead. The research on stem cells and disc degeneration is described in The science.
Patient stories.
A woman in her late 30s, a busy executive tied to her desk for long hours and overweight, developed persistent low back pain. She tried hospital treatment and acupuncture, and was prescribed ever stronger painkillers, which gave her gastritis. At times the pain was so severe she felt close to fainting. An MRI showed mild osteoarthritis of the spine, not enough for surgery, and every attempt to exercise and lose weight made the pain worse. After researching stem cell treatment she came to us. The injection went smoothly, and just one day later her back pain was 50% better. Her quality of life improved, she sleeps through the night without back pain, and she is gradually returning to exercise.
A patient came to us with years of chronic ankle inflammation from an old injury. To protect the weak ankle, the body had shifted load elsewhere, and the lower spine developed multiple bulging and herniated discs. The surgery on offer was risky and carried a real chance of failure. Because the problem sat in the ankle and several levels of the spine, we used an IV stem cell infusion. Within the first few days the patient described a substantial easing of pain and swelling in the ankle; disc and cartilage repair take longer, so the fuller picture emerges over the following months.
One patient treated for back and knee wrote: "I'm feeling great. My back has shown the most improvement so far (which needed it the most). For the first time in over 10 years I've been able to sleep on my stomach comfortably. My knee feels much better, and my mental clarity has improved significantly, with an improvement to my anxiety."
The science
Stem cell therapy has been hailed as a potential answer for many conditions, from wrinkles to spinal repair, and has shown promise in heart disease, Parkinson's disease and muscular dystrophy. In orthopaedics, the evidence is growing quickly.
How MSCs repair joints
Mesenchymal stem cells work largely through a paracrine effect: they secrete cytokines, growth factors and signaling vesicles that instruct the patient's own joint cells to begin repairing themselves. They also shift the local immune environment from inflammation toward healing, partly by encouraging inflammatory M1 macrophages to switch to anti-inflammatory M2 macrophages (Immunoregulatory paracrine effect of mesenchymal stem cells and mechanism in the treatment of osteoarthritis, Frontiers in Cell and Developmental Biology, 2024). They also provide chondroprotection, slowing the breakdown of cartilage (Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome, Frontiers in Bioengineering and Biotechnology, 2019).
Damaged or inflamed tissues send out signals that attract MSCs to the injury. This homing is why the cells can find sites of injury and inflammation (Mesenchymal Stem Cells Home to Sites of Injury and Inflammation, Journal of Inflammation Research). See also Caplan AI, "Mesenchymal Stem Cells: Time to Change the Name", Stem Cells Translational Medicine.
Cartilage repair
Cartilage is a flexible, resilient connective tissue covering the ends of bones in joints, letting them glide against each other with only slight friction. Unlike skin or even bone, cartilage cannot regenerate effectively once damaged, so after injury or wear, for example in the knee, repair options have traditionally been limited, leading to pain, reduced mobility and a poorer quality of life.
Cartilage problems are among the most common bone and joint problems, and left untreated they can lead to osteoarthritis. Current treatments such as microfracture and autologous chondrocyte implantation have shown only modest success, and whether they prevent or delay osteoarthritis is questionable. Stem cells have been proposed as a new era for cartilage disorders: their ability to become cartilage cells and to support healing makes them a strong candidate for non-surgical treatment of cartilage, which heals poorly. Research on stem cells in cartilage disorders has grown exponentially. MSCs are multipotent cells isolated from many tissues, including synovium, bone marrow, umbilical cord blood and fat, and have been seen to develop into bone, tendon, cartilage and muscle cells.
Several carriers have been used successfully with MSCs, such as platelet-rich fibrin glue and collagen scaffolds. All patients treated with MSCs in platelet-rich fibrin improved in clinical scores. In another study, a type I collagen scaffold carrying MSCs, with a bone graft sutured on top, was used in two patients, and both KOOS and IKDC scores improved significantly after surgery at 30 months of follow-up. A recent randomized trial in osteoarthritis suggested that MSCs improved cartilage quality on MRI, pain and quality of life compared with hyaluronic acid. On these data, MSCs can be a viable solution for focal cartilage defects in patients who prefer non-invasive treatment (Paschos NK, Sennett ML, "Update on mesenchymal stem cell therapies for cartilage disorders", World J Orthop. 2017 Dec 18; 8(12): 853–860).
In some cell therapy approaches, cells are taken from a healthy part of the patient's own body, expanded in the laboratory to a therapeutic dose, and reintroduced at the exact site of the cartilage defect. There they replicate and become cartilage cells, gradually generating new cartilage and mending the defect. Using the patient's own cells reduces the risk of rejection. Cell regeneration can be a good option alongside artificial joint replacement. Intra-articular injection of MSCs has been used successfully to resurface degenerated cartilage, leading to pain reduction and cartilage protection or healing.
Osteoarthritis
Osteoarthritis (OA) is the most common type of arthritis, affecting over 500 million people worldwide. The cartilage, the joint's natural cushioning and shock absorber, wears away, and the bones rub together more and more, causing pain, stiffness, swelling, reduced movement and sometimes bony growths along the bone edges.
Symptoms:
Loss of flexibility: you may not be able to move the joint through its full range.
Grating: a grinding feeling when you use the joint, sometimes with crackling or popping.
Bone spurs: extra bits of bone that feel like hard lumps around the joint.
Swelling, from inflammation of the soft tissue around the joint.
Pain during or after movement.
Stiffness, most noticeable on waking or after being inactive for a long time.
Tenderness when you press lightly on or near the joint.
Causes and risk factors. OA has many causes, local and systemic, and can occur at any age; particular genes are thought to play a role. Obesity, sports participation, genetic susceptibility and joint injury predispose young athletes to premature OA, and a history of knee trauma multiplies the risk of knee OA by 3.86. Risk factors for knee OA include age, trauma, muscle weakness, joint laxity, mechanical forces, repetitive knee trauma, kneeling, squatting, meniscal injuries, genetic susceptibility, obesity, female gender and bone density.
Prevention. Changes may not reverse OA, but they can lower your risk or slow its progression:
Keep a healthy weight. Excess weight puts more pressure on the knees and wears down cartilage over time. Excess fat also makes the body release cytokines, which can cause widespread inflammation and change how cartilage cells work.
Manage blood sugar. High blood sugar can affect the structure and function of cartilage, and diabetes increases the risk of cartilage loss and inflammation.
Exercise regularly. Moderate to intense activity keeps joints flexible, strengthens the muscles that support the knees and lowers the risk of many health problems; walking, gardening or swimming for 30 minutes, five times a week, may help. If you have not exercised for a long time, perhaps because of limited mobility, ask a medical professional how to start.
Reduce injury risk. Cartilage damaged by repeated injury is more likely to develop OA later. Wear well-fitting shoes to avoid slipping at home and use protective equipment in sport.
Avoid overuse. Some sports and jobs involve repetitive knee movement such as squatting or kneeling. People who regularly lift more than 25 kg may have a higher risk, as do jobs such as unloading trucks or ships and laying carpets. Varying activities and taking adequate rest breaks may help.
Conventional treatment. OA is degenerative and progressive, and damaged structures are unlikely to repair themselves, so conventional treatment manages symptoms until severity makes joint replacement necessary. Most treatments do not address the root cause, cartilage degeneration.
Rehabilitation. Physical therapy uses exercise to strengthen muscles and improve flexibility and joint mobility. Occupational therapy helps you cope with daily activities such as dressing, walking and bathing; you may need it only for a short time while you learn to manage OA or when symptoms flare. Alternative treatments include massage, relaxation therapies and hydrotherapy. Acupuncture may reduce OA symptoms when used with other medicines, or in some cases in place of pain medication.
Medication. Acetaminophen is often the first-line treatment for mild to moderate OA pain; common side effects include upper stomach pain and nausea. If it does not help, NSAIDs such as ibuprofen or naproxen may be used, but these can sometimes cause stomach problems.
Hyaluronic acid. Hyaluronic acid (HA) is a natural glycosaminoglycan made by cells inside the joint to produce joint lubricating fluid. It lubricates, absorbs shock and may have antioxidant and anti-inflammatory effects, but the evidence for its effectiveness is conflicting.
Joint injections. Steroid injections suppress the immune response and interrupt the inflammatory cascade at several levels, which is thought to improve mobility and relieve pain. Hyaluronic acid injections into the knee tend to be less beneficial than steroid injections, and the 2013 American Academy of Orthopaedic Surgeons guidelines strongly recommend against hyaluronic acid for symptomatic knee OA.
Stem cells and osteoarthritis: the evidence.
Researchers from the Krembil Research Institute, University Health Network, Toronto, Canada, studied whether mesenchymal stromal cells (which can develop into bone, muscle and, importantly, cartilage) could regenerate and repair knee cartilage. They recruited 12 patients with moderate to severe knee OA, took MSCs from each patient's bone marrow and, as a main aim of this pilot study was to establish a safe and effective dose, injected each patient with one of three doses. Over 12 months they measured inflammatory biomarkers, the rate of cartilage breakdown and MRI scans, and asked patients to rate how they were doing. By the end of the year, pain had decreased and quality of life had increased significantly, and inflammation inside the knee had fallen significantly, which is crucial because inflammation is now considered a key driver of OA. The results were published in the journal STEM CELLS Translational Medicine.
In another study, each patient was injected in a single knee. At five years, the injected knees were in better shape than before the injections, even though natural deterioration of the knee continues.
A 2020 meta-analysis in Stem Cells International found that patients given MSC therapy had significant improvements in pain and function compared with controls (Yin W, et al., Stem Cells International, 2020, Article ID 8835813, https://doi.org/10.1155/2020/8835813).
A 2022 randomized controlled trial in The American Journal of Sports Medicine reported less pain and better cartilage quality in patients with knee OA after umbilical cord-derived MSCs (Freitag J, et al., 2022).
A study in Clinical Orthopaedics and Related Research showed that MSC injections helped delay the need for joint replacement in many patients over a 2-year follow-up.
Further reading: "Effectiveness of mesenchymal stem cells for treating patients with knee osteoarthritis: a meta-analysis toward the establishment of effective regenerative rehabilitation"; Jo CH, et al., Stem Cells Translational Medicine, 2017, 6(2), 613–623; Vega A, et al., Transplantation, 2015, 99(8), 1681–1690; Davatchi F, et al., "Joint regeneration via mesenchymal stem cells: long-term outcomes", Clinical Rheumatology, 2020; Thai Ministry of Public Health, "Approved Stem Cell Therapy Guidelines", 2023.
In short, research supports MSC therapy as a safe and effective alternative for early to moderate osteoarthritis, especially for patients who want to avoid surgery or reduce their dependence on medication.
Placenta extract for osteoarthritis
Placenta extract is another cellular therapy used for knee OA. Human placental extract has been used for decades in Japan and China to treat liver and endocrine disorders and to support regeneration, and it has shown wound-healing, anti-inflammatory and antioxidant effects in clinical trials. It supports natural healing through nervous, hormonal and immune regulation and carries a variety of nutrients, growth factors and antioxidants. In OA, its anti-inflammatory action works against pain, its tissue-repair ability promotes regeneration of damaged tissue, and its insulin-like growth factor enhances the growth of smooth muscle cells and cartilage.
Professor Kazuhito Asano and his team at Showa University's School of Medicine found high levels of active oxygen in the joints of people with OA and rheumatoid arthritis, which is likely a cause of degeneration and pain. They measured active oxygen in the joints of 40 OA patients and 19 rheumatoid arthritis patients and found none in the joints of healthy people. With symptoms graded into four levels, the patients with the most severe symptoms had on average 2.5 times (OA) and five times (rheumatoid arthritis) the active oxygen levels of those with the mildest symptoms. They concluded that active oxygen damages joint tissue and drives degeneration. Because placenta extract can eliminate active oxygen, it may play an additional helpful role in treating both conditions.
Disc degeneration
Back pain is a major cause of disability worldwide, yet there is still no universally accepted treatment that fully restores the function of worn-out discs. Stem cells have shown promise for regenerating discs affected by degenerative disc disease.
How discs age. As discs age, their strength and structure change as the cells respond to wear and tear. More tears appear in the tissue, small particles form, and new blood vessels grow in from the outer part of the disc. The inner nucleus pulposus becomes less jelly-like and more fibrous, and clefts form through the outer part of the disc, so the disc gradually shrinks and loses height. The outer edges harden and thin, tiny fractures form in the neighboring bone, the bone thickens, and the blood vessels in the disc's cartilage end plates decrease markedly. The reduced blood supply worsens the shortage of nutrients, leading to low oxygen, waste build-up and an acidic environment, which impairs the disc cells' ability to make and maintain the extracellular matrix. These changes in the matrix drive disc degeneration.
Surgery versus non-surgical care. The study "One-year Outcomes of Surgical versus Non-surgical Treatments for Discogenic Back Pain: A Community-based Prospective Cohort Study" (Sohail K. Mirza, Richard A. Deyo, Patrick J. Heagerty, Judith A. Turner, Brook I. Martin and Bryan A. Comstock) found that both surgery and non-surgical approaches had modest outcomes. Patients seeking surgery had moderate pain and disability, and those who had surgery with other treatments improved somewhat more than those continuing non-surgical care. However, only a third of surgical patients achieved a successful outcome, and surgery was associated with more restrictions and more opioid use. Non-surgical care, often not following guidelines, showed minimal improvement. The study suggests that even basic conservative care may lead to significant improvement, and highlights how hard discogenic back pain is to treat.
Cell-based therapies. Beyond surgery, recent attention has turned to reversing and repairing disc degeneration. Stem cells, biologic growth factors and gene therapy have been tested, and these new approaches have shown some promising results in reversing the degenerative cascade (Fernandez-Moure J, "Novel therapeutic strategies for degenerative disc disease: review of cell biology and intervertebral disc cell therapy", SAGE Open Medicine, Volume 6: 1–11).
A review of six cohort studies gathered 78 participants treated with mesenchymal stem cells injected into the disc, followed for 6 to 72 months. They showed a significant mean improvement in the Oswestry Disability Index (ODI) and the visual analog pain scale (VAS) compared with controls where present, although the improvement appeared limited to a group of 51 responders (65.4%). In most studies disc height on MRI was not restored, but Pettine et al. (2015) reported an improvement of at least one Pfirrmann grade in eight participants at the 12-month MRI (Loibl M, "Controversies in regenerative medicine: Should intervertebral disc degeneration be treated with mesenchymal stem cells?", JOR Spine, 2019; 2: e1043).
Soufi et al. explored stem cell regenerative therapy for degenerative disc disease and low back pain in "Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review" (International Journal of Molecular Sciences, May 17, 2023). A clinical trial is testing the safety and effectiveness of human umbilical cord mesenchymal stem cells (hUC-MSCs) for lumbar degenerative disc disease: 20 people with lumbar disc herniation receive an injection of hUC-MSCs; the main outcome is the change in lumbar disc MRI signal at 3, 6 and 12 months compared with baseline; secondary outcomes include the disc height index on X-ray and the position of the herniated nucleus pulposus on MRI; and participants are monitored for treatment-related and serious adverse events for 12 months. Preclinical studies have shown that umbilical cord MSCs can survive and take on a cartilage-cell-like form when injected into the disc.
Clinically, choosing suitable candidates and measuring their improvement objectively is difficult, because back pain is complex and has many causes. Restored disc height could be a sign of improvement, but pain relief has been seen without it. Not all back pain comes from the discs, and stem cell therapy is usually considered for back pain linked to degenerative disc disease.
Risks of injection into the disc. Like any surgery, intradiscal procedures carry some risks: damage to nearby tissues and nerves, failure to relieve pain, the need for further surgery, infection and damage to the disc.
Recovery after surgery
Sometimes surgery is unavoidable, and it needs significant recovery time; a long recovery is a common reason people put surgery off. Regenerative medicine can now help you heal after surgery using your body's own healing capacity, with less pain and a shorter recovery. Mesenchymal cells have a potent ability to repair musculoskeletal tissue such as cartilage and bone: they can multiply and develop into bone, muscle, cartilage and other cells, and when injected they help the body regenerate tissue in the injured area. We use umbilical cord tissue stem cells that have never been frozen. The treatment is minimally invasive and done in the clinic, with no hospital stay or downtime.
Because stem cell therapy relies on the body's natural healing, it can take a few weeks to feel the benefits, as the cells need time to replace injured cells and build healthy tissue. You may not notice improvement for the first three weeks, but your body is already repairing your tissues. Most patients notice improvement within six weeks, with continued improvement over several months.
IV stem cells or joint injection?
Both are tools, not rivals, and the right choice depends on your condition, goals and the medical expertise guiding you.
IV (intravenous) stem cell therapy infuses MSCs into the bloodstream. They circulate through the whole body, home in on areas of inflammation or injury, guided by chemical distress signals from the damaged tissue, and release cytokines and growth factors that aid healing. After IV delivery the cells are first held briefly in the lungs before redistributing to where they are needed, so this is a whole-body, signal-driven approach rather than a guaranteed single-target one. IV therapy is suited to autoimmune diseases (such as lupus and rheumatoid arthritis), recovery of the lungs after COVID, chronic inflammation, fatigue and brain fog, and general anti-aging and wellness. Its benefits are whole-body cellular communication, immune modulation, less systemic inflammation, a mild non-invasive experience, and suitability for repeat sessions. It uses a higher, systemic dose, is usually painless, and has minimal downtime.
Joint injection delivers stem cells directly into a damaged or arthritic joint. This focused approach stimulates cartilage repair, reduces joint inflammation and slows degeneration. It is suited to osteoarthritis, sports injuries (ligament damage, meniscus tears), tendon injury and chronic localized joint pain. Its benefits are local pain reduction, better joint function, cartilage and soft-tissue regeneration, fewer systemic effects, and often fewer sessions than IV. It uses a lower dose concentrated on one site, with minimal to no downtime.
When problems exist in several places at once, an IV infusion lets the cells travel through the circulation toward multiple sites of inflammation. For a single, isolated joint, a direct injection may be the better choice. Many patients combine both.
Frequently asked questions
Who performs the injection?
The doctors are fully qualified and internationally trained in stem cell therapy, but because joint treatments are delicate, the injection is always given by an orthopaedic surgeon. Placing the cells correctly in the joint is not something to delegate casually, so we never have a general practitioner perform it.
Is the treatment painful? Will I need general anesthesia?
No general anesthesia is needed. We use local anesthesia only, to minimize any discomfort, and ultrasound guidance for precision. You may feel brief discomfort during the injection.
How long does it take to see results?
It varies between individuals. Some patients feel less pain and inflammation within the first few days. For knee arthritis, reduced pain and better function usually start to show within a month and gradually increase. Tendon, cartilage and disc repair is slower and unfolds over weeks to months; in our shoulder patients, the major gains were clear by around eight months. Early improvement is encouraging, but the result is best judged over a longer period.
How long do results last?
Results vary by condition.
How many sessions will I need?
This depends on your condition, and your doctor decides after an in-person assessment. Some patients benefit from one session, while others need two or three.
How long do I need to stay in Bangkok?
The minimum stay for joint stem cell treatment is just one day. We offer pre- and post-treatment support remotely after you go home.
Is stem cell therapy better than steroid injections?
They do different things. Steroid injections suppress inflammation and pain quickly, but they do not repair worn tissue, so relief can fade, and repeated use can weaken tendons and cartilage. Stem cell treatment aims to support actual tissue repair, which is why it can help patients for whom injections have stopped working. The best option depends on your diagnosis.
Is stem cell treatment an alternative to spinal surgery?
For some patients, yes, particularly when the goal is to reduce inflammation and support the body's own repair rather than remove or fuse tissue. It is not right for every case: severe structural problems or nerve compression may still need surgery. The point is to explore conservative options first, before irreversible surgery, when it is clinically reasonable.
Can I combine IV stem cells and a joint injection?
Yes. Many patients receive IV stem cells for whole-body support and joint injections for local repair in the same treatment plan.
Is PRP the same as stem cell treatment?
No. Some places offer PRP (platelet-rich plasma, made by spinning the patient's blood) and call it stem cells. Stem cells are new cells grown in a biological laboratory; PRP is extracted from your own blood. The two differ greatly in effectiveness.
Does a luxury clinic guarantee good quality?
No. According to an article on stem cell fraud in Thailand in Thailand Medical News, many clinics, especially in high-end areas such as Sukhumvit, offer stem cell treatment in a luxury setting without a certified doctor on site, some using doctors who graduated outside Thailand, such as in the Philippines, or even just a nurse. This is against Thai law, and if you are treated somewhere without proper credentials, nobody will take responsibility for side effects or consequences. We have heard of many such tricks and their consequences. Research the clinic itself, not only its marketing: stem cells are a proper and effective treatment only in the right place and with the right knowledge.
Do more cells mean a better result?
Not necessarily. The route of injection, the number of cells and, above all, cell quality affect results. Good-quality stem cells can multiply inside the body, while poor-quality cells quickly die, leaving millions of dead cells for the body to clear, which may in turn cause illness. Large cell numbers are often associated with frozen cells, where many cells die. Think of it as fighting a battle with a thousand undernourished soldiers or with a hundred well-trained young ones.
Is it safe to travel to Thailand for treatment?
Yes. We regularly treat patients from overseas, including from Singapore, the UAE, Australia, Hong Kong and the USA, and support you before and after treatment remotely. We do not run paid advertising: nearly all of our patients come to us by word of mouth, often through a friend we have treated.
George writes about his own experience with this on Stem cells for joints.
← All treatments in the Healthspan Library